Spreading misleading information about competing drugs can be an infringement of competition law

On 22 July 2024, the European Commission (EC) announced that it will be imposing certain commitments on Vifor, a manufacturer of intravenous iron medicines. Vifor is a dominant player in this market and had spread misleading information about the safety of a competing drug, Monofer, to healthcare professionals. The EC had opened an investigation, suspecting a potential […]